Go Jelly, go

Jellagen is one of the first commercial manufacturers of next-generation jellyfish collagen for cell culture and medical applications, inlcuding wound care and regenerative medicine. At the beginning of May it could raise £3.8m through the finance support of Newable Private Investing, one of the UK’s leading private investment groups and angel investors. “By sourcing collagen from jellyfish, Jellagen takes a sustainable approach to the medical, pharmaceutical and biotech industries“, states Anthony Clarke, managing director at Newable Private Investing. “It is exciting start-ups like Jellagen that are giving the UK economy an innovation boost and we’re delighted to support them in this funding round.”

The new funding builds on earlier investment secured from Newable, Angels in MedCity and the Development Bank of Wales, which helped Jellagen launch a first of its kind manufacturing facility for the extraction of collagen from jellyfish at its Cardiff site. The facility recently received the key quality certification ISO 13485:2016. The medtech and biomaterial company will use the funding to accelerate sales of its products into the cell culture market and regenerative medicine, whilst growing its specialist management team and strengthening its intellectual property portfolio.